Page last updated: 2024-08-17

spironolactone and gkt137831

spironolactone has been researched along with gkt137831 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, X; Li, J; Li, Q; Lu, G; Xiao, Y; Xie, D; Zhai, Y; Zhang, J	1

Other Studies

1 other study(ies) available for spironolactone and gkt137831

Article	Year
Spironolactone suppresses aldosterone-induced Kv1.5 expression by attenuating mineralocorticoid receptor-Nox1/2/4-mediated ROS generation in neonatal rat atrial myocytes. Biochemical and biophysical research communications, 2019, 12-03, Volume: 520, Issue:2 Topics: Aldosterone; Angiotensin II; Animals; Animals, Newborn; Heart Atria; Kv1.5 Potassium Channel; Myocytes, Cardiac; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; Pyrazoles; Pyrazolones; Pyridines; Pyridones; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Mineralocorticoid; Spironolactone	2019

Article

Year

Spironolactone suppresses aldosterone-induced Kv1.5 expression by attenuating mineralocorticoid receptor-Nox1/2/4-mediated ROS generation in neonatal rat atrial myocytes.

Biochemical and biophysical research communications, 2019, 12-03, Volume: 520, Issue:2

Topics: Aldosterone; Angiotensin II; Animals; Animals, Newborn; Heart Atria; Kv1.5 Potassium Channel; Myocytes, Cardiac; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; Pyrazoles; Pyrazolones; Pyridines; Pyridones; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Mineralocorticoid; Spironolactone

2019